Category Archives: Texas Stem Cells

The Neuropathy & Pain Centers of Texas is helping Fort Worth, Texas patients stop chronic pain with customized non-invasive treatment options to address your unique health needs and meet your health goals. We specialize in Advanced Regenerative Cell Therapy that offers safe and effective solutions for patients with a wide array of conditions. Our expert staff focuses on total body health and works with you to design your personal path to ending your chronic pain and reclaiming your life. Our innovative Advance Regenerative Cell Therapy has been proven effective in treating degenerative arthritic conditions, hip, knee, shoulder and elbow joint conditions, rotator cuff tendonitis, Achilles tendonitis and carpal tunnel syndrome.

Traditional treatment plans often rely on medications with dangerous side effects and risky invasive surgeries, but The Neuropathy & Pain Centers of Texas in Fort Worth is focused on providing patients an alternative path to healing and living a pain free life with Advanced Regenerative Cell Therapy that helps you avoid these harmful options. Patients living with chronic pain from degenerative joint conditions like hip osteoarthritis regularly endure steroid injections, never-ending pain medication protocols and joint replacement surgery often with little to no relief from their pain. Advanced Regenerative Cell Therapy treatments work to heal the underlying cause of your chronic pain and gives patients long-term results they can trust instead of just masking symptoms.

At The Neuropathy & Pain Centers of Texas we take creating a personalized patient experience seriously so its only natural that we provide a revolutionary treatment like Advanced Regenerative Cell Therapy that works with your body on a cellular level with cutting edge healing power. Advanced Cell Therapy commands growth factors and cytokines to the affected area and helps to repair and regenerate bone, ligaments, tendons and cartilage. Our skilled staff is dedicated to helping you stop chronic pain with a healthy, safe, non-invasive treatment. Call our team Fort Worth, Texas today and discover how Advanced Regenerative therapy can change your life.

Neuropathy & Pain Centers of Texas offers functional medicine, including physical therapy and stem cell therapy in Fort Worth, TX, 76132 and Arlington, TX, 76010. For your FREE consultation, call us today at 817-618-6443 in Fort Worth or 817-678-8558 in Arlington.

Go here to see the original:
Fort Worth Stem Cells | Neuropathy and Pain Centers of Texas

As most people today know, stem cells play an essential role in tissue regeneration. They replace cells that have died as a result of the aging process. (Stem cells also are responsible for regeneration and rejuvenation following cellular injury or damage that is not related to the aging process).

Do you know that over 10 million cells in your body die every second? These cells need to be regenerated and replaced which can be possible through the stem cell rejuvenation Therapy!

Stem Cells Defined

In simplest terms, a stem cell is an unspecified cell that can both self-renew (i.e., reproduce itself) and differentiate into many types of mature cells, (from collagen, to skin, to cartilage, to heart, to lung, to pancreas, and so on.) Consequently, stem cells are a key component of attaining and maintaining good health and well-being across the lifespan, and of achieving the full 120 years promised to us by God in Genesis 6:3. This is because stem cells have the capability to change into other types of cells, which gives them enormous regenerative and rejuvenating power. In other words, stem cells can keep us young and in prime health!

Most of the FDA-approved stem cell therapy in California, United States today is Autologous. Autologous stem cells are stem cells taken from the same individual who will receive the graft of the extracted stem cells. (In other words, autologous means that the individual is both the donor and the recipient.)

The Basics of Stem Cell Rejuvenation Therapy

Stem cells can be collected from peripheral blood, adipose (fat) tissue or bone marrow. Adipose tissues have more stem cells but fewer growth factors, while peripheral blood cells have fewer stem cells but more growth factors in the plasma component of the blood. Therefore, a combination of these two sources of stem cells-peripheral blood cells and adipose tissue-offers the best of both worlds, so to speak, allowing for more stem cells and more growth factors. In addition, the collection of stem cells from peripheral blood cells and adipose tissue is less painful than collection from bone marrow while yielding more stem cells than bone marrow. It is widely known that the age of the donor and the donors level of growth factors, such as IFG-1 (insulin growth factor), HGH (human growth hormone), testosterone, and estrogen, are directly proportional to the quantity and quality of the donors stem cells. (Remember, in the case of Autologous stem-cell therapy, the same individual is both donor and recipient). Thus, total hormone supplementation/replacement program plays an essential role in stem cells. In order to have a good quantity and quality of stem cells collected, we check the levels of growth factors in the donor before starting therapy.

The Role of Bio-identical Hormones and Growth Factors in Stem Cells

IGF-1, HGH, and other Growth Factors.

IGF-1 is a growth-hormone-related protein and a growth factor that we use to measure and estimate the level of HGH (Human Growth Hormone) in each individual. Again, we use IGF-1 for this purpose because the level of HGH in the body fluctuates on an hourly basis throughout the every 24-hour period, whereas the level of IGF-1 in the body does not fluctuate. Lets more deeply examine the scientific findings related to IGF-1, HGH and stem-cell growth.

Life Technologies in Maryland has conducted much research in this area. Their researchers have reported the increase of cell growth in studies of human stem cells cultured in IGF-1 (4ug/ml) of controlled medium. This growth was reported after six days in the culture, at which time cell numbers increased from 100,000 to 500,000.

Researchers at the University of Wurzburg in Germany have reached similar conclusions and have in fact expanded upon the results described above. To summarize the conclusion of my German colleagues, Age-dependent impairment of stem cells is corrected by growth hormone-mediated increase of IGF-1.

The Wurzburg research team further reported the following results from studies of middle-aged (57.4, plus or minus 1.4 years) males, as well as elderly (older than 58.8) and young (younger than 56) male subjects.

Furthermore, cellular aging is associated with an increased risk for atherosclerosis (so-called hardening of the arteries), a possible cause of which is low stem-cell numbers and dysfunctional endothelial stem cells that insufficiently repair damaged vascular walls. (Endothelial cells line the interior surface of blood vessels and lymphatic vessels.) Growth-hormone-mediated increase of IGF-1 improved the situation in the subjects in the Wurzburg study who received growth hormone (recombinant GH 0.4mg/d) over a ten-day period.

Conducting separate studies related to the administration of growth hormones, medical researchers in Texas have reported conclusions similar to what we have discussed thus far. Specifically, GH administration selectively augments the outgrowth of stem-cell population in healthy individuals, which supports GH replacement in the setting of adult GH deficiency in order to maintain vascular integrity; this has positive implications for the use of GH in future regenerative cell-based therapies.

Furthermore, the decrease in stem cells observed as part of the aging process may in part be explained by the decline of GH, thereby contributing to cardiovascular senescence (aging/ deterioration). The Texas research teams studies suggest that stem cells impact vascular health by modulating vascular repair and function: current evidence demonstrates that both the number of stem cells and their functionality are restored/ regenerated as a result of growth-hormone-mediated IGF-1; therefore, modulation of GH and IGF-1 may provide a useful therapy in the prevention of age-associated changes in the cardiovascular system and in future regenerative cell-based therapies.

The supportive findings continue. Another research team in the Netherlands, working independently of the teams described above, concluded that one year of recombinant GH replacement in adults with GH deficiency improved endothelial function and increased the number of circulating stem cells, which strengthens and corroborates the conclusions discussed thus far.

In 2012, the Nobel Prize in Medicine was awarded to Dr. Yamanaka who, continuing the work of British scientist Dr. Gurdon, discovered that reprogramming in cells (for example an adipose tissue cell) can be accomplished by just four transcription factors (OCT4, SOX2, KLF4, C-MYC.) Transcription factors are proteins made by master genes to regulate other genes. By injecting the four transcription factors into an adult cell of any type Dr. Yamanaka showed that he could lead the cell back to its primitive, or stem cell, form.

This type of discovery shows how important it is to have these growth factors, which are in the plasma of the donor, be transplanted together and at the same time with the adipose tissue cells in cosmetic procedures.

Now that we have thoroughly examined the importance of IGF-1, HGH and Growth Factors, lets explore some of the other essential hormones as related to the quantity and quality of the stem cells in our bodies, and to the total hormone supplementation/replacement therapy program.

Estrogen and Pregnenolone Influence the Quantity and Quality of the Stem Cells in Our Bodies

Lets examine the effects of estrogen on stem cells and the human bodys capacity for stem cell regeneration/rejuvenation. (Remember that estrogen is a female sex hormone.) In general, estrogen offers significant benefits among diverse stem-cell populations. Specifically, estrogen increases the proliferation of embryonic neural stem cells and accelerates differentiation of neurons during neurogenesis (growth of nerve cells), which suggests that estrogen may play a role in transplantation of neural stem cells as part of a therapeutic approach to neurodegenerative disease. Separate clinical research on estrogen indicates that premenopausal women presented the highest level of circulating stem cells (1.4 per 10,000 cells), while postmenopausal women presented the lowest (4 per 1,000,000 cells); moreover, the level of stem cells increased significantly with bio-identical hormone replacement therapy, on average by 25.5 percent.

Another key hormone, Pregnenolone, promotes the proliferation of human stem cells (also called progenitor cells), making Pregnenolone vital to both stem cell replacement therapy and the total hormone replacement/supplementation therapy program.

Thyroid Hormones and Melatonin Hormone Also Influence the Quantity and Quality of Our Stem Cells

Whereas Pregnenolone works to proliferate stem cells in a more aggregate manner, T3 (a thyroid hormone) promotes cardiac differentiation and maturation of embryonic stem cells; that is, embryonic stem cells can differentiate into functional cardiomyocytes (cardiac-muscle cells), meaning that T3 promotes stem-cell growth of heart-muscle tissue.

Finally, we must consider melatonin, which behaves as a preconditioning agent that increases the survival of stem cells. Using melatonin for pretreatment of stem cells may represent a new a new safer approach to improving the beneficial effects of stem-cell therapy administered to solid organs, as appeared to be the case following an intraparenchymal injection of melatonin into an ischemic kidney. (The kidney was considered ischemic because of a deficient supply of blood as a result of an obstructed inflow of arterial blood to the organ.)

With each passing day, more innovative and exciting research takes place in the groundbreaking field of stem cell rejuvenation therapy. To be sure, the findings will only proliferate, reinforcing our existing knowledge that bio identical hormonal treatment all play an essential role in maintaining the quantity and quality of the stem cells in our bodies.

More:
Stem Cell Rejuvenation Therapy | Totalhormonegenetherapy.com

Dennis M. Lox, M.D. Knee Stem Cell Treatments have been seen Across The Nation.

Dennis M Lox, M.D. is an expert in Knee Stem Cell Injections for those who seek an alternative to the unnecessary complex knee surgery of that in the past by providing Knee Stem Cell Treatment. Dennis M. Lox, M.D. has privately owned Medical Centers that do not partake in the fast chain franchise that other Stem Cell Centers are stuck doing, thus he is able provide a more personalized treatment for your particular injury.

Dennis M. Lox, M.D. centers have a professional, caring environment for patients looking for comfort in their time of need and provids follow-ups on your wellbeing to enhance your recovery. Dennis M. Lox, M.D. has been helping patients since 1990 nationally and internationally and has been the focus of the Stem Cell News Worldwide with his expertise and he continually researches new technologies to further Stem Cell advancements.

PUBLICATIONS:

Lox, D.M., Heine, M.W., and Lox, C.D., Hemostatic Alterations Resulting from Chronic Ethanol Ingestion during Tetracycline Therapy in the Rat, Neurobeh, Toxiocol: Vol. 7, 1985.

Lox, C.D. and Lox, D.M., Effects of Acute Ethanol Intoxication Combined with Secobarbitol Abuse on Homeostasis, General Pharm Vol. 16, 1985. 252-258.

PRESENTATIONS:

Lox, D.M., Sports Medicine and Stem Cells: A Clinical Transformation Presentation at the Select Biosciences Conference: Tissue Engineering and Bio printing, Boston, Massachusetts, February 2015

Lox, D.M., Clinical Regulation of Cytokine and Inflammatory Pathways with Autologous Stem Cell Therapy Presentation at the 17th Clinical Applications for Age Management Medicine Group, The Bellagio Hotel, Las Vegas, Nevada, October 2014

Lox, D.M., Moderator 3rd Annual International Conference on Tissue Science and Regeneration, Valencia, Spain, September 2014

Lox, D.M., Athletes and Avascular Necrosis Presentation at the 3rd Annual International Conference on Tissue Science and Regeneration, Valencia, Spain, September 2014Lox, D.M., Managing Sports and Arthritic Complaints with Stem Cells, Presentation at the Select Biosciences Clinical Translation of Stem Cells, Palm Desert, California, April 2014

Lox, D.M., A Professional Football Player with Failed Knee Surgery: A Case of Treatment with Adipose Derived Stem Cells, Presentation at the Tissue Engineering and Regenerative Medicine International Society Asia Chapter (Termis AP) Annual Conference, Shanghai, China, Oct. 2013

Lox, D.M., Chronic Foot Pain in a Ballerina: Treatment with Regenerative Medicine Presentation at the Tissue Engineering and Regenerative Medicine International Society Asia Pacific Chapter (Termis AP) Annual Conference, Shanghai, China, October 2013

Lox, D.M., Knee Osteoarthritis: Quality of Life (Q o L) Measures Following Autologous Stem Cell Therapy Presentation at the International Cartilage Repair Society Annual Meeting, Izmir, Turkey, September 2013

Lox, D.M., Cytokine Modulation with Nutraceuticals as a Synergistic Mechanism for Regenerative Grafting in Osteoarthritis Repair Presentation at the Tissue Engineering and Regenerative Medicine International Society Meeting, Istanbul, Turkey, June 2013

Lox, D.M., Arthritis: Quality of Life (Q o L) Measures following Mesenchymal Stem Cell Therapy Presentation at the Tissue Engineering and Regenerative Medicine International Society Meeting, Istanbul, Turkey, June 2013

Lox, D.M., Can Healthcare Outcomes Be Quantified with Stem Cell Therapy in Osteoarthritis?

Presentation at the World Stem Cell Summit, West Palm Beach, Fl. December 2012

Lox, D.M., Regenerative Rehabilitation of an Elite Soccer Player, Presentation at the First Annual Symposium on Regenerative Rehabilitation, Pittsburgh, PA, November 3-4, 2011.

Lox, D.M., Regenerative Medicine and Tissue Engineering: Ethical Concerns with Health Care Reform, Presentation at the 2011 World Stem Cell Summit, Pasadena, CA on October 2011.

Lox, D.M., Autologous Adipose-Derived Stem Cells in the Rehabilitation of a Soccer Player, Presentation at the Stem Cells Europe 2011 Conference, Edinburgh, Scotland on July 2011.

Lox, D.M., Autologous Human Adipose-Derived Mesenchymal Stem Cells in Orthopedic Medicine: A Veterinary Correlate, Presentation at the 2nd North American Veterinary Regenerative Medicine Conference, Lexington, Kentucky on June 2011.

Lox, D.M., Regenerative Medicine Techniques in Musculoskeletal Medicine, Presented at the

11th Annual Conference of the International Neural Transplantation and Repair, Sand Key, FL on May 2011.

Lox, D.M., Current Regenerative Medicine Techniques, Tampa, Florida on July 10, 2010.

Lox, D.M., Complex Regional Pain Syndrome Course Presentation, American Academy of Physical Medicine and Rehabilitation Annual Assembly (Moderator: Dennis M. Lox, M.D. Speakers: Jose Ochoa, M.D., Gabor Racz, M.D., Dennis M. Lox, M.D.); Seattle, Washington on November 5, 1998.

Lox, D.M., New Treatments in Myofascial Pain and Fibromyalgia, Presented at the Morton Plant/Mease Health Education Center Countryside, Florida on December 13, 2001.

Lox, D.M., Acute Spinal and Pain Syndromes Presented to the Pinellas County Primary Care and OB/GYN physicians, sponsored by Knoll Pharmaceuticals, 1998.

Lox, D.M., Complex Musculoskeletal Assessment and Treatment, Presented to the Zenith Insurance Company; Sarasota, Florida on September 28, 1998.

Lox, D.M., Fibromyalgia, Presented to Cigna Health Care Physicians, sponsored by Health South Rehabilitation Corporation; Tampa, Florida on September 19, 1998.

Lox, D.M., Evaluation of the Difficult Pain Patient, Presented to the Pinellas County Orthopedic Journal Club, sponsored by Knoll Pharmaceuticals; Clearwater, Florida on September 8, 1998.

Lox, D.M., Fibromyalgia, Presented to the Travelers Insurance Company, sponsored by Health South Rehabilitation Corporation; Tampa, Florida on August 19, 1998.

Lox, D.M., Complex Pain Management, Presented to the Physicians of Collier County, sponsored by Knoll Pharmaceuticals; Naples, Florida on May 16, 1998.

Lox, D.M., Managing Pain in a Managed Care, Presented to the Pinellas County Podiatric Medical Association Meeting; Clearwater, Florida on April 14, 1998.

Lox, D.M., Complex Regional Pain Syndrome: The Historical Perspective from Bonica and Beyond, Presented at the 7th Annual John J. Bonica Vail Winter Pain Conference, sponsored by the Ohio State University Medical Center, College of Medicine, Department of Anesthesiology; Vail, Colorado on March 1998.

Lox, D.M., Pain Management, Presented to Lee County Physicians, sponsored by Knoll Pharmaceuticals; Ft. Myers, Florida in December 1998.

Lox, D.M., Managing Pain in a Managed Care Environment, Presented to the Pinellas County Physicians, sponsored by Knoll pharmaceuticals; Clearwater, Florida in December 1997.

Lox, D.M., Regional Pain Syndrome Update, Presented at the 74th Annual Meeting of the American Congress of Rehabilitation Medicine Pain ISIG; Boston, Massachusetts in September 1997.

Lox, D.M., Physical Medicine for Women Who Hurt all Over (Physical and Somatization Considerations, and Complex Regional Pain Syndrome Update, Presented at the 9th Annual OB/GYN Summer Symposium, Womens Health Care in the 90s, sponsored by the University of Oklahoma Health Sciences Center College of Medicine, Department of Obstetrics and Gynecology; Jackson Hole, Wyoming in August 1997.

Lox, D.M., Replacing the Terms of Reflex Sympathetic Dystrophy and Sympathetically Maintained Pain-An Uphill Battle, Presented at the 13th Annual Update in Physical Medicine and Rehabilitation, sponsored by the University of Utah School of Medicine, Division of Physical Medicine and Rehabilitation, Park City, Utah, March 1997.

Lox, D.M., Complex Regional Pain Syndrome, Presented to Claim Management, Utilization Management, Case Managers, Adjustors and Supervisors of the Travelers/Aetna Insurance Companies; Orlando, Florida in August 1996.

Lox, D.M., Soft Tissue Injuries/RSD/Fibromyalgia-The Rational or Irrational Approach to Diagnosis and Treatment, Presented to Claim Management, Utilization Management, Case Managers and Supervisors of Travelers Insurance Company; Tampa, Florida, 1996.

Lox, D.M., Overview of the Soft Tissue Injury/RSD/Fibromyalgia-The Rational or Irrational Approach to Diagnosis and Treatment, Presented to the Regional Adjustors and Personnel of Geico Insurance Company; Macon, Georgia in May 1996.

Lox, D.M., Causalgia/RSD/SMP-History and Treatment, Presented during the Re-Employment rules of Florida Workers= Compensation Conference, sponsored by the Southwest Chapter of NARPPS in May 1996 (2 CME credits).

Lox, D.M., RSD-Treatment Options for the 90s, Presented to the Florida Association of Rehabilitation Professionals in the Private Sector (FARPPS) in March 1996 (2 CME credits).

Lox, D.M., Causalgia/RSD/SMP-The 100 Year War, Presented to The Florida Association of Rehabilitation Professionals in the Private Sector in January 1996 (2 CME credits)

Lox, D.M., The Differential Diagnosis of Spinal Injuries, Presented to the Intracorp Rehabilitation Nurses in April 1992 (4 CME credits).

Lox, D.M., A Physiatrist Approach to Industrial Industries, Presented to the Florida Rehabilitation Nurses in May 1991 (4 CME credits).

Lox, D.M., Skiing Injuries: Prevention and Rehabilitation, Presented at the North American Medical and Dental Association Seminar; Vail, Colorado in February 1989.

Lox, D.M., The Failed Back Patient, Presented at the Annual Texas Physical Medicine and Rehabilitation Society Meeting; Austin, Texas in August 1989.

Lox, D.M., Dermatomal Somatosensory Evoked Potentials and Gadolinium-MRI in the Evaluation of Chronic Low Back Pain, Presented at the 50th Annual Session of the American Academy of Physical Medicine and Rehabilitation; San Antonio, Texas in November 1989.

Lox, D.M., The Evaluation and Treatment of Lumbar Spine Disorders, Presented at the University of Texas Health Science Center at San Antonio, Department of Allied Health; San Antonio, Texas in December 1988.

Read the original here:
Our Doctors - Knee Stem Cells

Foot and ankle wounds are very common among athletes, and a considerable lot of these wounds can be dealt with non-carefully with stem cell therapy, platelet-rich plasma or prolotherapy, depending upon the nature of the damage. Ankle arthritis is also essential as we age, although many of us may experience joint pain sooner than expected because of ankle damage in our younger days. Stem cell therapy in Dallas offers the country's most developed stem cell and platelet medications for foot and ankle wounds and degenerative conditions. Look for Texas stem cell treatment center & get in touch with us today for an appointment, our stem cell therapy centers in USA is famous for stem cell therapy texas we have expert surgeons for various treatment such as foot therapy Dallas. We are one of the best stem cell treatment centers in USA which are very popular for stem cell therapy in USA.

The term arthritis is utilized to describe different conditions that demolish the inner workings of your joints. Pain can occur in any joint of your body, including your ankles and any of the 30 joints in each foot.

Osteoarthritis is the most widely common form. This dynamic illness gradually wears away joint cartilage and results from the wear and tear of maturity. It implies osteoarthritis is well on the way to strike after middle age.

Rheumatoid joint pain (RA) is a fiery malady that irritates the joint lining and causes torment. The condition can strike at any age and affect any joint. People who have lived with RA for a long time or all the more quite often experience the condition in their feet or ankles. Opt for foot therapy Dallas & get the treatment.

Post-traumatic arthritis creates the following damage. It can happen following a broken bone, torn ligament or moderate lower leg sprain, regardless of whether the damage gets proper restorative attention. Visit stem cell clinics in USA & get the appropriate treatment.

Regardless of what degree or sort of arthritis you're experiencing, texas stem cells treatment center will provide therapy which decreases the effect of pain.

Half of adults age 60 to 80 have joint pain in their feet and don't know it since they experience no side effects. In case you're not one of the fortunate ones, your ankle and foot arthritis is probably going to cause these symptoms:

Pain and solidness, making it hard to walk regularly

Delicate joints that feel warm to the touch

Twisted ankles and toes

Deadness and shivering spreading from the affected joint

At the point when the above treatment choices aren't sufficient, you have another choice before you fall back on medical surgery: stem cell therapy texas. On account of ongoing recent strides in healthcare and science, stem cell therapy centers in USA are more effective than any other time at treating arthritis of the ankle and foot. The method is necessary and non-careful, involving simply a single in-office injection.

Stem cell therapy in Dallas can frequently effectively replace ordinary arthritis medicines, for example, taking mitigating drugs.

Arthritis

Instability

Plantar fasciitis

Peroneal ligament agony or damage

Ligament pain or injury

Subtalar arthritis or insecurity

Bunions

The human body keeps a supply of stem cells accessible to help repair harmed and degenerated tissues consistently, making it genuinely easy to recover them for therapeutic purposes.

As stem cells stay available for later, in the marrow cavity of your bones, we have discovered the easiest place to harvest these stem cells is from the back of the hip area (iliac bone).

The methodology is done in the office, under ultrasound or x-ray exactness and direction.

Patients lay face down as the specialist thoroughly cleans the area before numbing the skin and bone.

A special needle is embedded into the issue that remains to be worked out marrow blood, which contains the stem cells.

After bone marrow blood is drawn, it is taken to the research facility and centrifuged to concentrate and purify the stem cells while other cells that are not required are removed, leaving a concentrated example of stem cells used to help heal your damage.

The whole procedure is done in Texas stem cells treatment center by surgeons to empower altered designing of the stem cell example for your specific damage.

Preparation of your concentrated platelets are additionally gathered as of now for injection into the damage site to release growth factors that "turn on" the stem cells that will later be injected.

These platelets are infused again 3 after 5 days to keep the stem cells actuated and advance extra healing.

There are many stem cell clinics in, but very few clinics are specialized in their work if you are a person & want to avoid surgery the look for stem cell therapy in Dallas & get the therapy from the expert therapist. Texas stem cell treatment center has the potential to heal many types of damaged tissue, opt for stem cell treatment centers in USA & consult with an expert.

Continued here:
Stem Cell Treatment Center in Dallas, Texas | Stem Cell ...

Physical Medicine in Fort Worth, Neuropathy & Pain Centers of Texas uses physical rehabilitation, medical pain relief, and other effective medicaltreatments to address a wide range of conditions, such as chronic pain. In Fort Worth and Arlington, youll find no clinic more committed to helping patients achieve their wellness goals, and no more highly trained and competent staff of medical professionals. Providing more than just Physical Medicine in Fort Worth, Neuropathy and Pain Centers of Texas is able to provide relief for a variety of issues, because we are an integrated functional medicine practice, specializing in not only the treatment of acute and chronic pain, but also natural health and wellness. For instance, if youre seeking a solution for your migraines in Fort Worth, youll want to find a clinic that addresses the source of your problem, rather than treating you like a collection of symptoms. Because our staff is dedicated to finding the root cause of medical issues, we are able to find and address these problems, utilizing physical medicine treatments that include: drug-free pain relief, physical therapy and cold laser therapy. In Fort Worth, youll find no more competent ally in addressing conditions that include but are not limited to:

At Neuropathy & Pain Centers of Texas, we provide physical medicine Fort Worth residents can trust. If youre seeking physical medicine in Fort Worth, Texas, or you just want to learn how achieve your own optimal wellness, its time to call for a consultation. Call Neuropathy & Pain Centers of Texas Today Neuropathy & Pain Centers of Texas offers functional medicine, including physical therapy in Fort Worth, TX, 76132 and Arlington, TX, 76010. For yourFREE consultation, call us today at(817) 953-2723

Original post:
Neuropathy & Pain Centers of Texas - Stem Cells & Neuropathy

At Achieve Vitality, we want to help you feel better faster naturally. If you live every day with pain from an injury or condition, youve probably forgotten what relief feels like. At our clinic, weve teamed up with medical experts to bring you back to your optimal health through our natural therapy. Stem cell therapy is changing your bodys pain, and theres no looking back.

We brought the power of stem cells to Garland, Texas. Now, you have more options for relieving your pain naturally. Many patients have been told their only option for relief is surgery or long-term medication. With stem cell therapy there is hope. With one simple injection, your body can regenerate itself from the inside out with results in weeks. Youll return to a better life in no time.

Dr. Darcy Brunk, DC

Dr. Darcy Brunk is one of the leading medical professionals in Garland, Texas. Hes an experienced chiropractor with experience relieving a variety of injuries and conditions. He knows just how frustrating it can be to live with daily pain. When he was unable to help more extreme patients optimize their health, he knew there had to be a better way. This is what caused him to hire a medical team and research on stem cell therapy. Dr. Brunk and his medical team knew stem cell therapy was the solution they had been waiting for. Now, Dr. Brunk and his professional medical team can help a variety of patients feel their best while still sticking to his principles of natural healing.

We want you to live life in less pain with the powerful stem cell therapy. Listen to our stem cell success stories to see how these powerful cells can help your body to relieve itself naturally. Contact us today to schedule a consultation to review whether stem cell therapy is right for you.

Dr. Liza Leal, MD

Dr. Liza Leal earned her medical degree from the Univesity of Texas Health Science Center- Medical School at Houston in 1996 and then completed her post-graduate training at St. Joseph Hospital in Houston Texas. She is an active Consultant and Director of Medical Development for physicians who are striving to establish pain management centers in their specific area of expertise. Along with her medical career, she is a public speaker for American Acadamy of Pain Management and the American Acadamy of Family Practice. Dr. Leals ambitions for her activism in medicine is to reach 86 million Americans who suffer from chronic pain with the help of her book: Live Well Today with Chronic Pain. Dr. Leals overall ambition in the medical field is to inspire and heal others to live their personal dream through the art of medicine and accomplish their individual goals.

Now Dr. Leal has joined the Achieve Vitality Regenerative Wellness team! She cant wait to start helping patients conquer their pain with stem cell therapy. With its newest member Achieve Vitality Regenerative Wellness team can enlighten more patients about the beauty behind stem cells and start receiving the treatment they need to live a healthy life again.

See the article here:
Stem Cell Doctor Dallas Dr. Darcy Brunk | Dallas, Plano ...

Reading Time: 7 minutes

Return to Human Cloning and Stem Cell Research

Cloned Human Embryonic Stem Cells

Cloned human embryonic stem cells are derived from a cloned human embryo created by asexual reproduction. Somatic cell nuclear transfer (SCNT) is the scientific term for one of the asexual processes by which a human being or animal is cloned. SCNT involves a donor egg from which the nucleus has been removed. The enucleated egg is then fused with the nucleus from a cell of the person to be cloned, yielding a cloned human embryo that begins to divide and grow in the same fashion as an embryo created by traditional reproduction. This process of human somatic cell nuclear transfer is the identical method by which animals have been successfully cloned and birthed (e.g., Dolly the Sheep, CC the cat, cattle, etc.).

How are cloned embryonic stem cells obtained?

When the cloned human embryos reach 5 to 7 days, stem cells are extracted from the inner mass of the cloned embryos. Such dismemberment kills the cloned human embryo.

What diseases are being treated with cloned embryonic stem cells?

No health benefits or cures have been realized in animal trials using cloned human embryonic stem cells. This lack of clinical evidence, coupled with the appearance of dangerous side effects in animals (the formation of tumors), has discouraged the use of cloned embryonic stem cells in human clinical trials.

What are the challenges of using cloned embryonic stem cells?

Cloned human embryos are difficult to create. Only one laboratory in South Korea has created cloned human embryos and grown them to the point where stem cell extraction is possible. Hundreds of eggs were needed to create just one cloned embryo. In addition, animals injected with cloned embryonic stem cells have developed cancer and tumors due to the unpredictable and immature nature of the genetically altered and cloned embryonic stem cells.

What ethical concerns are linked to the use of cloned embryonic stem cells?

The use of cloned embryonic stem cells requires the creation of a human life solely for the purpose of lethal scientific experimentation, and therefore, carries serious ethical implications. Furthermore, regulations ensuring that these cloned human embryos will not be implanted in the womb to birth a human clone would be impossible to enforce.

How will a human cloning ban affect the use of cloned embryonic stem cells?

Cloned human embryonic stem cell research is the only type of stem cell research prohibited by a human cloning ban.

Embryonic Stem Cells

Embryonic stem cells are derived from the human embryos created for infertile couples at in vitro fertilization (IVF) clinics. In the laboratory, IVF clinics unite sperm from the father and an egg from the mother to create a child to implant in the mothers womb. Some parents decide not to implant and birth all their embryonic children; these left-over embryos may be placed for adoption, disposed of, or donated to research. In order to be used by scientists for research, parents must explicitly donate their embryonic children with informed consent, including clear acknowledgement that scientific experimentation will result in the death of their embryonic child.

How are embryonic stem cells obtained?

Embryonic stem cells are typically extracted after the frozen embryo is thawed and allowed to develop to four or five days old. Because the cells are taken from the inner cell mass of the embryo, the embryo dies during the extraction process. Embryonic stem cells extracted from donated embryos are used to start stem cell lines.

What diseases are currently treated with embryonic stem cells?

No illnesses or diseases have been treated using embryonic stem cells. In fact, embryonic stem cells have created tumors when tested in animals because of their immature and unpredictable nature. Furthermore, these cells are often rejected due to the DNA mismatch with the patient.

What are the challenges of using embryonic stem cells?

Embryonic stem cells are not used in human clinical trials because there have been no successes in animal trials. The development of tumors and terratomas (masses of flesh with eyes, hair, and teeth) has discouraged FDA approval of the use of embryonic stem cell transplants in humans. Embryonic stem cells are difficult to use because scientists have been unable to:

Establish and maintain stable cell lines of embryonic stem cells

What are the ethical concerns of using embryonic stem cells?

Embryos created for the purpose of in vitro fertilization are created with the intent to birth children. Extracting stem cells from embryos created for, but not used in, in vitro fertilization does result in the death of a unique human life and, consequently, encompasses serious ethical implications.

Would a comprehensive ban affect the use of embryonic stem cells?

Neither a state or federal ban on human cloning would prohibit in any way embryonic stem cell research that involves embryos created through in vitro fertilization, because IVF embryos are not created by cloning.

Fetal Stem Cells

Fetal stem cells are stem cells extracted from the tissues of aborted or miscarried unborn children in the fetal stage.

How are fetal stem cells obtained?

Fetal stem cells are extracted from a miscarried or aborted unborn child in the fetal stage through a tissue or blood sample. The tissue or blood sample is treated with growth factors in the laboratory, and then injected into the body of the diseased or injured patient.

What diseases are treated with fetal stem cells?

No medical treatment derived from fetal stem cells has successfully treated any human disease. In one of the most well-known human clinical trials using fetal stem cells, the cells were injected into the brains of Parkinsons patients. Unfortunately, these unpredictable young cells created terratomas (masses of tissue with hair and teeth) and tumors, and patients experienced increased Parkinsons symptoms.

What ethical concerns are linked to the use of fetal stem cells?

Although fetal stem cell research does not cause the death of the unborn child (as the child is already deceased at the time of extraction), ethical consideration must be given to research that depends on the death of an unborn child (especially if that death is unnaturally induced).

Will a human cloning ban affect fetal stem cell research?

A human cloning ban would not prohibit in any way the use of fetal stem cells.

Adult Stem Cells

Adult stem cells reside throughout the human body within tissue, blood and organs; they are plentiful and readily available. Adult stem cells do not have to come from an adult; rather, adult refers to the stage or maturity of the stem cell, distinguishing the cell from those stem cells extracted from pre-born humans (embryos and fetuses). Adult stem cells are also found in the tissues of the umbilical cord (after live birth), spinal cord, fat, bone marrow, dental pulp, nasal cavity, brain, peripheral blood, blood vessels, skeletal muscle, skin, cornea, digestive system, retina, liver, and pancreas.

How are adult stem cells obtained?

Adult stem cells are drawn from the body of the patient in a tissue or blood sample without harm to the individual. The cells are then transferred to the laboratory where they are cultured and coaxed to multiply. A dozen extracted adult stem cells may multiply into millions of new cells that are genetically identical to the original extracted cells. After the cells multiply, the healthy cells are re-inserted into the body of the patient where the cells differentiate into the appropriate cell type. Human clinical trials show that these new cells travel to the diseased or injured body part and begin repair and tissue regeneration.

What human diseases or conditions are currently treated with adult stem cells?

While adult stem cell research is by no means a perfected process, there are dozens of human diseases and conditions that have been successfully treated with adult stem cells.

To what is the success of adult stem cell therapies attributed?

Adult stem cells have had proven success in laboratory culture, animal models of disease, and in human clinical treatments. Adult stem cells:

What are the challenges of adult stem cell research?

Sometimes adult stem cells are difficult to identify or distinguish from other cells due to their abundant presence throughout the body and varying appearances depending on their location.

What ethical concerns are linked to the use of adult stem cells?

Unlike other types of stem cell research, the procurement and use of adult stem cells never requires the creation or destruction of innocent human life, and therefore, no ethical challenges arise.

How will a comprehensive cloning ban affect adult stem cell research?

A human cloning ban would not prohibit in any way the use of adult stem cells.

Visit link:
Four Types of Stem Cells - Texas Right to Life

Texas Capitol. (Shutterstock)

In 2017 Texas passed a sweeping new law, HB 810, which allowed medical clinics to provide investigational stem cell treatments to patients with certain severe chronic diseases or terminal illnesses. Those in favor of the law argued that patients battling life-threatening or life-changing diseases should have the right to try stem cell therapies that were involved in a clinical trial.

Now a new study, published in the journal Stem Cells and Development, looks at the impact of the law. The report says that despite some recent amendments t there are still some concerns about the law including:

The researchers conclude:

While HB 810 opens up access to patients, it also increases significant risks for their safety and financial cost for something that might have no positive impact on their disease. Truly understanding the impact of stem cell based interventions (SCBI) requires scientific rigor, and accurate outcome data reporting must be pursued to ensure the safety and efficacy behind such procedures. This information must be readily available so that patients can make informed decisions before electing to pursue such treatments. The creation of the SCBI registry could allow for some level of scientific rigor, provide a centralized data source, and offer the potential for better informed patient choices, and might be the best option for the state to help protect patients.

Another CIRM-funded company gets RMAT designation

When Congress approved the 21st Century Cures Act a few years ago one of the new programs it created was the Regenerative Medicine Advanced Therapy (RMAT) designation. This was given to therapies that are designed to treat a serious or life-threatening condition, where early clinical stage trials show the approach is safe and appears to be effective.

Getting an RMAT designation is a big deal. It means the company or researchers are able to apply for an expedited review by the FDA and could get approval for wider use.

This week Poseida Therapeutics was granted RMAT designation by the Food and drug Administration (FDA) for P-BCMA-101, its CAR-T therapy for relapsed/refractory multiple myeloma. This is currently in a Phase 1 clinical trial that CIRM is funding

In this trial Poseidas technology takes an immunotherapy approach that uses the patients own engineered immune system T cells to seek and destroy cancerous myeloma cells.

In a news release Eric Ostertag, Poseidas CEO, welcomed the news:

Initial Phase 1 data presented at the CAR-TCR Summit earlier this year included encouraging response rates and safety data, including meaningful responses in a heavily pretreated population. We expect to have an additional data update by the end of the year and look forward to working closely with the FDA to expedite development of P-BCMA-101.

This means that five CIRM-funded companies have now been granted RMAT designations:

Like Loading...

Read the original post:
Texas | The Stem Cellar

There are very encouraging news for the field of stem cell research and especially for patients from Dallas with established disability as a result of stroke, diabetes, degenerative or inflammatory diseases where this is no proven treatment to aid recovery. Stem cell therapies are being already used all over the world with great outcomes; however, stem cells treatment is not legally approved in most clinics in Dallas and other cities in the United States.

Residents from Fort Worth, West University, University Park, Southlake, San Antonio, Highland Park, Bellaire and Colleyville, can now access one the most revolutionary treatments today. Contact us.

Costa Rica is one of the to destinies in medical tourism, due to its excellent healthcare systems and to its extraordinary natural resources, which makes Costa Rica your best choice to access legally approved therapies and save some money.

The Stem Cells Transplant Institute of Costa Rica specializes in the legal treatment of Parkinson, Cardiovascular Disease, Knee Injury, Multiple Sclerosis, Diabetes, Lupus, Osteoarthritis, Rheumatoid Arthritis, Critical limb isquemia, Erectile Dysfunction, Chronic Obstructive pulmonary disease, Alzheimer, Myocardial infarction and Neuropathy.Contact us.

At Stem Cells Transplant Institute in Costa Rica we believe that through these new, world-class therapies; our patients from Dallas will have significant benefits. We want you to access stem cells therapies with highest standards of quality in health care and values. Apply now.

Read more here:
Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth ...

June 12, 2017

House Bill (HB810) on stem cell therapy has passed in the Texas state legislature and become law. Patients in Texas will now have access to this Right to Try innovative form of therapy for those suffering with debilitating and incurable illnesses.

Rita Alexander, Chief Administrative Officer at StemGenex Medical Group in La Jolla, CA, applauded Texas for this landmark legislation and Republican State Rep. Drew Springer, R-Muenster, who strongly advocated for this bill. She noted that over the past three years, Right to Try advocates in 33 states have helped enact legislation to eliminate obstacles for terminally ill patients seeking treatments that may not be approved by the Food and Drug Administration (FDA).Those advocates are showing considerable momentum in the remaining 17 states, potentially expediting clinical therapies for patients who have limited options with current Texas stem cell laws.

At StemGenex, we are committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells, said Alexander. Specifically, we use adipose-derived adult stem cell therapy for patients battling conditions such as Multiple Sclerosis, Parkinsons disease, COPD, Rheumatoid Arthritis and Osteoarthritis. We are also committed to the science of stem cell therapy and sponsor five clinical outcome studiesregistered with theNational Institute of Health (NIH) for these diseases.

What I personally witnessed before the start of StemGenex were patients who had exhausted conventional medical treatments but wanted to try alternative therapies. I was one of them, suffering from severe Rheumatoid Arthritis. Ihad only three options; I could seek a clinical trial, travel to outside of the U.S. to try alternative therapies such as stem cell treatment or petition the FDA for access to drugs under the agencys expanded access, or compassionate use program. Now, new state laws like the one just passed in Texas, built on model legislation from the Goldwater Institute in Arizona, will allow doctors and patients to make their own informed decisions on treatments that have cleared the safety phase of FDA testing.

Last year, in a move that was seen by some as a response to Right to Try laws, the 21st Century Cures Act, a landmark piece of legislation focused on medical innovation and medical research, was signed into law by President Obama. This Act provides the FDA with the flexibility to accelerate how it evaluates regenerative medicine treatments, such as stem cell therapies, while maintaining its high standards of safety and efficacy.

Were on the cusp of a major change on how patients can access stem cell therapy, saidAlexander. Today, new treatments and advances in research are giving new hope to people affected by a wide range of autoimmune and degenerative illnesses, said Alexander. StemGenex Medical Group is proud to offer the highest quality of care and to potentially help those with unmet clinical needs improve their quality of life.

To find out if you are a candidate for treatment or to learn more about stem cell laws,Call (855) 742-7836to speak with a Patient Advocate or visitwww.StemGenex.com.

Originally posted here:
HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex